INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS OUTCOMES RESEARCH (EIN 223369741) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1995

Legal Domicile

Principal Officer

KATE TARPEY

Phone

6095864981

Tax Period

2024-01-01 to 2024-12-31

INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS OUTCOMES RESEARCH, founded in 1995, is a mid-sized nonprofit in the Medical Research sector that reported $19.7M in total revenue in fiscal year 2024.

Mission

PROMOTE GLOBAL HEALTH ECONOMICS AND OUTCOMES RESEARCH EXCELLENCE TO IMPROVE DECISION MAKING

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $18,544,488

Investment Income $1,107,744

Other Revenue $71,596

TOTAL REVENUE $19,723,828

Expense Breakdown

Grants Paid $0

Salaries & Benefits $9,249,275

Fundraising Expenses $0

Program Expenses $16,260,823

Other Expenses $10,113,885

TOTAL EXPENSES $19,363,160

Year-over-Year Comparison

	2024	2023	Change
Revenue	$19,723,828	$18,483,761	+0.1%
Expenses	$19,363,160	$17,227,897	+0.1%
Net Income	$360,668	$1,255,864	-0.7%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

1000

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$346,150

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
EBERECHUKWU ONUKWUGHA MS PHD	PRESIDENT (SINCE JUNE 2024)	2.00	Officer Director	$0	$0	$0
UWE SIEBERT MD MP SCD	PRESIDENT-ELECT	2.00	Officer Director	$0	$0	$0
BRIAN O'ROURKE	PAST PRESIDENT (SINCE JUNE 2024)	2.00	Officer Director	$0	$0	$0
SEAN SULLIVAN MSC PHD	TREASURER	2.00	Officer Director	$0	$0	$0
AMY K O'SULLIVAN PHD	DIRECTOR	2.00	Director	$0	$0	$0
RAMIRO GILARDINO MD MHS	DIRECTOR	2.00	Director	$0	$0	$0
DALIA DAWOUD PHD	DIRECTOR	2.00	Director	$0	$0	$0
DANIEL OLLENDORF PHD	DIRECTOR	2.00	Director	$0	$0	$0
ELISABETH FENWICK PHD MSC	DIRECTOR	2.00	Director	$0	$0	$0
KATJA RUDELL PHD MSC	DIRECTOR	2.00	Director	$0	$0	$0
LUCINDA ORSINI DPM MPH	DIRECTOR	2.00	Director	$0	$0	$0
BETH DEVINE PHD	DIRECTOR (UNTIL 06/24)	2.00	Director	$0	$0	$0
MARLENE GYLDMARK MPHIL	DIRECTOR (UNTIL 06/24)	2.00	Director	$0	$0	$0
ANDREA MANCA MSC PHD	DIRECTOR (UNTIL 06/24)	2.00	Director	$0	$0	$0
DONG-CHURL SUH PHD	DIRECTOR (UNTIL 06/24)	2.00	Director	$0	$0	$0
JAN ELIAS HANSEN PHD	PAST PRESIDENT (UNTIL JUNE 2024)	2.00	Officer Director	$0	$0	$0
SUSAN CAPON	CHIEF OPERATING OFFICER	40.00	Officer	$317,919	$28,231	$346,150
ELIZABETH LANE	CHIEF MARKETING OFFICER	40.00	Highest	$233,634	$31,859	$265,493
LAURA PIZZI	CHIEF SCIENCE OFFICER	40.00	Highest	$318,549	$12,273	$330,822
CHANTAL ALMONORD	CHIEF INFO & ENGAGEMENT OFFICER	40.00	Highest	$201,641	$34,293	$235,934
SEAN GORMLEY	DIRECTOR, BUSINESS DEVELOPMENT	40.00	Highest	$222,811	$36,692	$259,503
PAUL WONG	DIRECTOR, GLOBAL EVENTS	40.00	Highest	$204,550	$21,913	$226,463

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$19,723,828	$19,363,160	$30,224,428	$360,668
2023	$18,483,761	$17,227,897	$27,237,931	$1,255,864
2022	$14,593,000	$15,156,974	$23,939,884	$-563,974
2021	$8,054,618	$9,567,254	$24,515,564	$-1,512,636
2020	$14,162,413	$9,413,154	$26,278,189	$4,749,259
2019	$16,559,826	$15,114,605	$20,352,941	$1,445,221
2018	$16,282,259	$14,773,834	$17,365,453	$1,508,425

INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS OUTCOMES RESEARCH